User profiles for Chantal Reusken
chantal reuskenCentre for Infectious Disease Control-RIVM, the Netherlands Verified email at casema.nl Cited by 26923 |
[HTML][HTML] Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
…, M Peiris, H Goossens, C Reusken… - …, 2020 - eurosurveillance.org
Background The ongoing outbreak of the recently emerged novel coronavirus (2019-nCoV)
poses a challenge for public health laboratories as virus isolates are unavailable while there …
poses a challenge for public health laboratories as virus isolates are unavailable while there …
[HTML][HTML] Severe acute respiratory syndrome coronavirus 2− specific antibody responses in coronavirus disease patients
…, N Houhou-Fidouh, CBEM Reusken… - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
A new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has
recently emerged to cause a human pandemic. Although molecular diagnostic tests were …
recently emerged to cause a human pandemic. Although molecular diagnostic tests were …
[PDF][PDF] BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity
The tuberculosis vaccine bacillus Calmette-Guérin (BCG) has heterologous beneficial
effects against non-related infections. The basis of these effects has been poorly explored in …
effects against non-related infections. The basis of these effects has been poorly explored in …
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study
Background A new betacoronavirus—Middle East respiratory syndrome coronavirus (MERS-CoV)—has
been identified in patients with severe acute respiratory infection. Although …
been identified in patients with severe acute respiratory infection. Although …
Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation
…, SHS Al Dhahiry, CBEM Reusken… - The Lancet infectious …, 2014 - thelancet.com
Background Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe lower
respiratory tract infection in people. Previous studies suggested dromedary camels were a …
respiratory tract infection in people. Previous studies suggested dromedary camels were a …
Bats host major mammalian paramyxoviruses
The large virus family Paramyxoviridae includes some of the most significant human and
livestock viruses, such as measles-, distemper-, mumps-, parainfluenza-, Newcastle disease-, …
livestock viruses, such as measles-, distemper-, mumps-, parainfluenza-, Newcastle disease-, …
[HTML][HTML] Comparison of seven commercial RT-PCR diagnostic kits for COVID-19
…, R Molenkamp, CBEM Reusken… - Journal of clinical …, 2020 - Elsevier
The final months of 2019 witnessed the emergence of a novel coronavirus in the human
population. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has since spread …
population. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has since spread …
Virus genomes reveal factors that spread and sustained the Ebola epidemic
The 2013–2016 West African epidemic caused by the Ebola virus was of unprecedented
magnitude, duration and impact. Here we reconstruct the dispersal, proliferation and decline of …
magnitude, duration and impact. Here we reconstruct the dispersal, proliferation and decline of …
[HTML][HTML] Human betacoronavirus 2c EMC/2012–related viruses in bats, Ghana and Europe
We screened fecal specimens of 4,758 bats from Ghana and 272 bats from 4 European
countries for betacoronaviruses. Viruses related to the novel human betacoronavirus EMC/2012 …
countries for betacoronaviruses. Viruses related to the novel human betacoronavirus EMC/2012 …
Protection of COVID-19 vaccination and previous infection against Omicron BA. 1, BA. 2 and Delta SARS-CoV-2 infections
…, R Schepers, SJM Hahné, CBEM Reusken… - Nature …, 2022 - nature.com
Given the emergence of the SARS-CoV-2 Omicron BA.1 and BA.2 variants and the roll-out
of booster COVID-19 vaccination, evidence is needed on protection conferred by primary …
of booster COVID-19 vaccination, evidence is needed on protection conferred by primary …